Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Disorder Treatment

Part of paid clinical trials in Danville, Pennsylvania.

Sponsor
Geisinger Clinic
Study ID
NCT07197801
Status
Recruiting
Apply to this trial

Conditions

  • Opioid Use Disorder

Eligibility Criteria

Sex
ALL
Age
18 Years - 89 Years
Healthy Volunteers
Not accepted

Interventions

  • Peer recovery support to enhance patient engagement in medication for opioid use disorder treatment — BEHAVIORAL
    The intervention adds a peer recovery support (PRS) program to standard outpatient medication for opioid use disorder treatment and medical care. The PRS program will entail meeting one-on-one with a peer recovery specialist over a 6-month period, who will utilize their lived experience with substance use and recovery to provide emotional, informational, instrumental, and affiliational support to participants.

Study Details

The goal of this clinical trial is to learn if receiving peer recovery support (support services provided by trained "peers" with lived experience of addiction and recovery) improves retention in medication treatment among people with opioid use disorder. The main question it aims to answer is: does peer recovery support improve retention in medication treatment for opioid use disorder? Researchers will compare two groups: (1) standard care combined with a peer recovery support program, and (2) standard care alone, to see if peer recovery support works to improve retention in medication treatment for opioid use disorder. Participants will: visit clinics as they normally would to receive standard care (medication treatment for opioid use disorder); complete two questionnaires - one when they start treatment and one 6 months later; and agree to let researchers use information from their medical record. Participants in group 1 will also be invited to meet with a peer recovery support specialist for up to 6 months.

Key Dates

Start date
Dec 23, 2025
Status verified
Feb 2026
Primary completion
Jan 31, 2029
Completion
Jul 31, 2029

Study Design

Enrollment
218 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • No Intervention: Standard Care
    Study participants will receive the standard care - medication treatment for opioid use disorder
  • Experimental: Standard Care + Peer Recovery Support
    In addition to standard care (medication treatment for opioid use disorder), study participants will receive support provided by a peer recovery support specialist

Primary Outcome Measure

6-month treatment retention [ Time Frame: 180 days from initiation of medication treatment for opioid use disorder ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Geisinger ClinicDanvillePennsylvania17822
Melissa N Poulsen, PhD, MPH (PRINCIPAL_INVESTIGATOR)

Find similar trials in Danville, PA

By research site
Geisinger Clinic· Danville, PA

Related Studies